✦ LIBER ✦

Anaphylactoid reactions to Dextran 40 and 70: Reports to the United States Food and Drug Administration, 1969 to 2004

✍ Scribed by Zinderman, Craig E.; Landow, Laurence; Wise, Robert P.

Book ID: 122249724
Publisher: Elsevier Science
Year: 2006
Tongue: English
Weight: 90 KB
Volume: 43
Category: Article
ISSN: 1097-6809
DOI: 10.1016/j.jvs.2006.01.006

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Hepatotoxicity due to troglitazone: repo

Hepatotoxicity due to troglitazone: report of two cases and review of adverse events reported to the United States Food and Drug Administration

✍ James Kohlroser; Jijy Mathai; James Reichheld; Barbara F Banner; Herbert L Bonko 📂 Article 📅 2000 🏛 Nature Publishing Group 🌐 English ⚖ 240 KB

Replication of the Weber Effect Using Po

Replication of the Weber Effect Using Postmarketing Adverse Event Reports Voluntarily Submitted to the United States Food and Drug Administration

✍ Ms. Nicole R. Hartnell; Dr. James P. Wilson 📂 Article 📅 2004 🏛 John Wiley and Sons 🌐 English ⚖ 108 KB

The Food and Drug Administration Launche

The Food and Drug Administration Launches Program to Improve Safety of Drugs and Active Drug Ingredients Produced Outside the United States

✍ Les Lang 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 120 KB

Erratum to: The Weber Effect and the Uni

Erratum to: The Weber Effect and the United States Food and Drug Administration’s Adverse Event Reporting System (FAERS): Analysis of Sixty-Two Drugs Approved from 2006 to 2010

✍ Hoffman, Keith B.; Dimbil, Mo; Erdman, Colin B.; Tatonetti, Nicholas P.; Overstr 📂 Article 📅 2014 🏛 Springer International Publishing AG 🌐 English ⚖ 138 KB

Fractures of a Single Design of Highly C

Fractures of a Single Design of Highly Cross-Linked Polyethylene Acetabular Liners: An Analysis of Voluntary Reports to the United States Food and Drug Administration

✍ Ast, Michael P.; John, Thomas K.; Labbisiere, Anthony; Robador, Nicolas; Valle, 📂 Article 📅 2014 🏛 Elsevier Science 🌐 English ⚖ 739 KB

Comprehensive Biotechnology || Regulator

Comprehensive Biotechnology || Regulatory Aspects of Chemistry Manufacturing and Controls for Investigational New Drug Applications and Biologic License Applications to the United States Food and Drug Administration

✍ Lee, K. 📂 Article 📅 2011 🏛 Elsevier ⚖ 272 KB